Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2α correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 471-480

  Onita, Toru ^a,c   Guang Ji, Ping ^a   Xuan, Jim W ^a   Sakai, Hideki ^a,c   Kanetake, Hiroshi ^c   Maxwell, Patrick H ^b   Fong, Guo Hua ^a,d   Gabril, Manal Y ^a   Moussa, Madeleine ^a   Chin, Joseph L ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENDOTHELIAL PER ARNT SIM DOMAIN PROTEIN 1; HELIX LOOP HELIX PROTEIN; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; URINARY TRACT CANCER; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANOXIA; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL MOVEMENT; DISEASE PROGRESSION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MACROPHAGES; MALE; MIDDLE AGED; NECROSIS; NEOVASCULARIZATION, PATHOLOGIC; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANS-ACTIVATORS; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036190869     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Endothelial PAS domain protein I (EPAS1), a transcription factor selectively expressed in endothelial cells
2. The transcription factor EPAS-1/hypoxia-inducible factor 2α plays an important role in vascular remodeling
3. Impaired cued and contextual memory in NPAS2-deficient mice
4. The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
5. Angiogenesis: How a tumor adapts to hypoxia
6. Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia-inducible factor-1α
7. Expression of ARNT, ARNT2, HIF1 α, HIF2 α and Ah receptor mRNAs in the developing mouse
8. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development
9. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 α and developmentally expressed in blood vessels
10. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular Oz tension
11. The hypoxia-responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development
12. Cloning and expression pattern of EPAS-1 in the chicken embryo colocalization with tyrosine hydroxylase
13. The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages
14. Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
15. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
16. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
17. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
18. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
19. Relationship of hypoxia-inducible factor (HIF)-1α and HIF-2α expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines
20. Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system
21. Angiogenesis in colorectal tumors: Microvessel quantitation in adenomas and carcinomas with clinicopathological correlations
22. Tumor induction of VEGF promoter activity in stromal cells
23. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer
24. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
25. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
26. Up-regulation of vascular endothelial growth factor in stromal cells of hemangioblastomas is correlated with up-regulation of the transcription factor HRF/HIF-2α
27. Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression
28. Expression of vascular endothelial growth factor by macrophages is up-regulated in poorly vascularized areas of breast carcinomas
29. Quantitative assessment of the leukocyte infiltration in ovarian cancer and its relationship to the expression of C-C chemokines
30. Activation of coagulation and angiogenesis in cancer, immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer
31. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
32. Production of vascular endothelial growth factor by murine macrophages
33. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages
34. Different angiogenic pathways characterize superficial and invasive bladder cancer
35. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression
36. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder
37. EPAS1 trans-activation during hypoxia requires p42/p44 MARK
38. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice
39. Molecular mechanisms of transcription activation by HLF and HIF1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300
40. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
41. Targeting gene expression to hypoxic tumor cells